E Fund Management’s IDEAYA Biosciences IDYA Stock Holding History

E Fund Management’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$337K	Sell	9,045 -1,852	-17%	-$56.7K	0.01%	363
2026 Q1	$363K	Buy	+10,897	New	+$366K	0.01%	350
2025 Q2	$257K	Buy	12,225 +881	+8%	+$16.9K	0.01%	329
2025 Q1	$186K	Buy	11,344 +2,980	+36%	+$63.5K	0.01%	366
2024 Q4	$215K	Buy	8,364 +267	+3%	+$7.56K	0.01%	354
2024 Q3	$257K	Buy	8,097 +799	+11%	+$30.3K	0.01%	279
2024 Q2	$256K	Sell	7,298 -2,214	-23%	-$87.7K	0.01%	255
2024 Q1	$417K	Sell	9,512 -873	-8%	-$37.5K	0.03%	204
2023 Q4	$369K	Buy	+10,385	New	+$310K	0.02%	203

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

E Fund Management's IDYA Position: Q2 2026 in Review

E Fund Management reduced its IDEAYA Biosciences (IDYA) stake by 17% in Q2 2026, selling an estimated $56.7K and leaving 9,045 shares worth $337K. The position accounts for 0.01% of the portfolio, ranked #363.

E Fund Management first reported a position in IDYA in Q4 2023 and has held it in 9 quarters since. The position peaked at $417K in Q1 2024. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

E Fund Management held 9,045 shares of IDEAYA Biosciences worth $337K as of Q2 2026.
E Fund Management sold 1,852 IDEAYA Biosciences shares in Q2 2026, an estimated $56.7K.
IDEAYA Biosciences made up 0.01% of E Fund Management's portfolio in Q2 2026, its #363 holding.
E Fund Management first reported a position in IDEAYA Biosciences in Q4 2023 and has held it in 9 quarters since.
E Fund Management's IDEAYA Biosciences position peaked at $417K in Q1 2024.
284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.